{"disease":{"id":"hiv-2-infection","name":"hiv 2 infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04971343","title":"Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol","phase":"","overall_status":"COMPLETED","enrollment_count":8650,"lead_sponsor_name":"Beckman Coulter, Inc.","has_results":false},{"nct_id":"NCT04658329","title":"Cohorte Nationale VIH-2","phase":"","overall_status":"UNKNOWN","enrollment_count":1185,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT02150993","title":"First-Line Treatment for HIV-2","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT03394196","title":"RESIST-2: 2nd-line ART for HIV-2 Infection","phase":"NA","overall_status":"TERMINATED","enrollment_count":152,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT05215704","title":"Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Erasmus Medical Center","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}